Technology transfer          
 
Project consultancy          
 
Certification services
 
Information services         
 
Biosafety
 
Biotech Industrial Training Programme                      
 
Project management         
Technology Transfer
 
BCIL acts as an interface between technology sources and technology seekers both within and outside the country. By virtue of the network of national and international linkages established by BCIL, it assists in technology sourcing, , marketing tie-ups and identification of joint venture partners.

For details about the methodology adopted for transfer of technologies, technologies available and technologies transferred please click the links below:
Methodology
Technologies available
Technologies transferred
 
   

Dr. Purnima Sharma, Managing Director, BCIL, Dr. G. P. Talwar, Principal Trustee & Director Research, Talwar Research Foundation and Dr. Ajay George Varghese, CEO, M/s Bipha Drug Laboratories (Pvt.) Ltd, Kottayam, Kerala signing a license agreement for the transfer of “BASANT- A Novel, Broad spectrum, Clinically Proven Antimicrobial Herbal Formulation” developed by a team led by Dr. G. P. Talwar in presence of Dr. Soumya Swaminathan, Director General, Indian Council of Medical Research, New Delhi 1st day of June 2017.

 
   

Dr. Purnima Sharma, Managing Director, BCIL and Mr. Suresh O. Agrawal, Managing Director, Bejo Sheetal Seeds Pvt. Ltd. signing a license agreement for the transfer of Viral Promoters technology developed by Dr. Indranil Dasgupta, Professor, Department of Plant Molecular Biology, University of Delhi South Campus in presence of Dr. M. K. Bhan, Secretary, DBT, New Delhi and others on 24th Day of November, 2008.

 
   

Dr. Purnima Sharma, Managing Director, BCIL and Mr. P. V. Mohan Rao, Director, M/s. Pasura Biotech Private Limited signing a license agreement for the transfer of Bollcure technology developed by Dr. Nutan Kaushik, Fellow & Area Convenor - Plant Biotechnology, The Energy and Resources Institute (TERI) in presence of Dr. M. K. Bhan, Secretary, DBT, New Delhi and others on 21st Day of October, 2008.

 
   

Transfer of technology for production of recombinant Vi-conjugate typhoid vaccine developed at AIIMS, New Delhi and assigned to BCIL (Licence agreement executed between Dr. Purnima Sharma, ED & CEO, BCIL and Shri Prashant Tewari, MD, USV Limited, Mumbai in the presence of Dr. M.K. Bhan, Secretary, DBT, on July 19, 2006)

 
   

Signing of Letter of Consent between BCIL (Dr. Purnima Sharma, ED & CEO) and ICMR (Dr. K. Satyanarayana, DDG) for transfer of Biotechnologies developed through ICMR support (in presence of Dr. N.K. Ganguly, Director General, ICMR and Dr. V.P. Kamboj, Chairman, BCIL, on September 25, 2007).